These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 31097920)

  • 1. CD36-Mediated Lipid Accumulation and Activation of NLRP3 Inflammasome Lead to Podocyte Injury in Obesity-Related Glomerulopathy.
    Zhao J; Rui HL; Yang M; Sun LJ; Dong HR; Cheng H
    Mediators Inflamm; 2019; 2019():3172647. PubMed ID: 31097920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palmitate aggravates proteinuria-induced cell death and inflammation via CD36-inflammasome axis in the proximal tubular cells of obese mice.
    Li LC; Yang JL; Lee WC; Chen JB; Lee CT; Wang PW; Vaghese Z; Chen WY
    Am J Physiol Renal Physiol; 2018 Dec; 315(6):F1720-F1731. PubMed ID: 30230367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD36 Promotes Podocyte Apoptosis by Activating the Pyrin Domain-Containing-3 (NLRP3) Inflammasome in Primary Nephrotic Syndrome.
    Yang X; Wu Y; Li Q; Zhang G; Wang M; Yang H; Li Q
    Med Sci Monit; 2018 Sep; 24():6832-6839. PubMed ID: 30258045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purinergic 2X7 Receptor is Involved in the Podocyte Damage of Obesity-Related Glomerulopathy via Activating Nucleotide-Binding and Oligomerization Domain-Like Receptor Protein 3 Inflammasome.
    Hou XX; Dong HR; Sun LJ; Yang M; Cheng H; Chen YP
    Chin Med J (Engl); 2018 Nov; 131(22):2713-2725. PubMed ID: 30425198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of NLRP3 inflammasome ameliorates podocyte damage by suppressing lipid accumulation in diabetic nephropathy.
    Wu M; Yang Z; Zhang C; Shi Y; Han W; Song S; Mu L; Du C; Shi Y
    Metabolism; 2021 May; 118():154748. PubMed ID: 33675822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adiponectin protects obesity-related glomerulopathy by inhibiting ROS/NF-κB/NLRP3 inflammation pathway.
    Xu X; Huang X; Zhang L; Huang X; Qin Z; Hua F
    BMC Nephrol; 2021 Jun; 22(1):218. PubMed ID: 34107901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD36 aggravates podocyte injury by activating NLRP3 inflammasome and inhibiting autophagy in lupus nephritis.
    Lv F; He Y; Xu H; Li Y; Han L; Yan L; Lang H; Zhao Y; Zhao Z; Qi Y
    Cell Death Dis; 2022 Aug; 13(8):729. PubMed ID: 35999224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Triptolide inhibits NLRP3 inflammasome activation and ameliorates podocyte epithelial-mesenchymal transition induced by high glucose].
    Wu W; Liu BH; Wan YG; Sun W; Liu YL; Wang WW; Fang QJ; Tu Y; Yee HY; Yuan CC; Wan ZY
    Zhongguo Zhong Yao Za Zhi; 2019 Dec; 44(24):5457-5464. PubMed ID: 32237395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of NLRP3 Inflammasome Activation and Inflammatory Exosome Release in Podocytes by Acid Sphingomyelinase During Obesity.
    Huang D; Kidd JM; Zou Y; Wu X; Gehr TWB; Li PL; Li G
    Inflammation; 2023 Oct; 46(5):2037-2054. PubMed ID: 37477734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NLRP3 inflammasome activation contributes to aldosterone-induced podocyte injury.
    Bai M; Chen Y; Zhao M; Zhang Y; He JC; Huang S; Jia Z; Zhang A
    Am J Physiol Renal Physiol; 2017 Apr; 312(4):F556-F564. PubMed ID: 28052869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-17A participates in podocyte injury by inducing IL-1β secretion through ROS-NLRP3 inflammasome-caspase-1 pathway.
    Yan J; Li Y; Yang H; Zhang L; Yang B; Wang M; Li Q
    Scand J Immunol; 2018 Apr; 87(4):e12645. PubMed ID: 29446486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Podocyte-specific silencing of acid sphingomyelinase gene to abrogate hyperhomocysteinemia-induced NLRP3 inflammasome activation and glomerular inflammation.
    Huang D; Kidd JM; Zou Y; Wu X; Li N; Gehr TWB; Li PL; Li G
    Am J Physiol Renal Physiol; 2024 Jun; 326(6):F988-F1003. PubMed ID: 38634138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nod-like receptor protein 3 (NLRP3) inflammasome activation and podocyte injury via thioredoxin-interacting protein (TXNIP) during hyperhomocysteinemia.
    Abais JM; Xia M; Li G; Chen Y; Conley SM; Gehr TWB; Boini KM; Li PL
    J Biol Chem; 2014 Sep; 289(39):27159-27168. PubMed ID: 25138219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rac1 GTPase Inhibition Blocked Podocyte Injury and Glomerular Sclerosis during Hyperhomocysteinemia via Suppression of Nucleotide-Binding Oligomerization Domain-Like Receptor Containing Pyrin Domain 3 Inflammasome Activation.
    Zhang Q; Conley SM; Li G; Yuan X; Li PL
    Kidney Blood Press Res; 2019; 44(4):513-532. PubMed ID: 31266025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD36 promotes NLRP3 inflammasome activation via the mtROS pathway in renal tubular epithelial cells of diabetic kidneys.
    Hou Y; Wang Q; Han B; Chen Y; Qiao X; Wang L
    Cell Death Dis; 2021 May; 12(6):523. PubMed ID: 34021126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective Action of Anandamide and Its COX-2 Metabolite against l-Homocysteine-Induced NLRP3 Inflammasome Activation and Injury in Podocytes.
    Li G; Xia M; Abais JM; Boini K; Li PL; Ritter JK
    J Pharmacol Exp Ther; 2016 Jul; 358(1):61-70. PubMed ID: 27189966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lower plasma PCSK9 in normocholesterolemic subjects is associated with upregulated adipose tissue surface-expression of LDLR and CD36 and NLRP3 inflammasome.
    Cyr Y; Lamantia V; Bissonnette S; Burnette M; Besse-Patin A; Demers A; Wabitsch M; Chrétien M; Mayer G; Estall JL; Saleh M; Faraj M
    Physiol Rep; 2021 Feb; 9(3):e14721. PubMed ID: 33527668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Podocyte Activation of NLRP3 Inflammasomes Contributes to the Development of Proteinuria in Lupus Nephritis.
    Fu R; Guo C; Wang S; Huang Y; Jin O; Hu H; Chen J; Xu B; Zhou M; Zhao J; Sung SJ; Wang H; Gaskin F; Yang N; Fu SM
    Arthritis Rheumatol; 2017 Aug; 69(8):1636-1646. PubMed ID: 28544564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coptidis Rhizoma inhibits NLRP3 inflammasome activation and alleviates renal damage in early obesity-related glomerulopathy.
    Ren Y; Wang D; Lu F; Zou X; Xu L; Wang K; Huang W; Su H; Zhang C; Gao Y; Dong H
    Phytomedicine; 2018 Oct; 49():52-65. PubMed ID: 30217262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NLRP3 inflammasome as a novel target for docosahexaenoic acid metabolites to abrogate glomerular injury.
    Li G; Chen Z; Bhat OM; Zhang Q; Abais-Battad JM; Conley SM; Ritter JK; Li PL
    J Lipid Res; 2017 Jun; 58(6):1080-1090. PubMed ID: 28404641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.